Cell Biotech Co., Ltd. (KOSDAQ:049960)
12,930
0.00 (0.00%)
At close: May 30, 2025, 3:30 PM KST
Cell Biotech Revenue
Cell Biotech had revenue of 11.23B KRW in the quarter ending March 31, 2025, a decrease of -13.87%. This brings the company's revenue in the last twelve months to 48.10B, down -10.89% year-over-year. In the year 2024, Cell Biotech had annual revenue of 49.91B, down -7.20%.
Revenue (ttm)
48.10B
Revenue Growth
-10.89%
P/S Ratio
1.84
Revenue / Employee
453.81M
Employees
106
Market Cap
88.49B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 49.91B | -3.87B | -7.20% |
Dec 31, 2023 | 53.79B | 3.26B | 6.46% |
Dec 31, 2022 | 50.53B | 3.65B | 7.79% |
Dec 31, 2021 | 46.87B | 1.29B | 2.83% |
Dec 31, 2020 | 45.58B | -377.42M | -0.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.10T |
SK hynix | 71.40T |
Samsung Biologics | 4,898.69B |
LG Energy Solution | 25.76T |
Hyundai Motor Company | 178.98T |
KB Financial Group | 14.93T |
Hanwha Aerospace | 15.28T |
HD Hyundai Heavy Industries | 15.32T |